Mesalazine Hydrochloride is an aminosalicylate anti-inflammatory agent primarily indicated for the treatment of inflammatory bowel diseases, including ulcerative colitis and Crohn's disease. By modulating… Read more
Mesalazine Hydrochloride is an aminosalicylate anti-inflammatory agent primarily indicated for the treatment of inflammatory bowel diseases, including ulcerative colitis and Crohn's disease. By modulating local inflammatory responses within the gastrointestinal tract, it serves as a critical therapeutic option for patients requiring maintenance or acute management of these conditions. This category provides essential reference standards for the rigorous analytical testing of this active pharmaceutical ingredient. These materials include pharmacopeial and non-pharmacopeial impurities, key metabolites, and stable isotope-labelled compounds, all of which are vital for accurate impurity profiling. Pharmaceutical laboratories rely on these high-quality standards for precise method validation and routine quality control protocols, ensuring that both drug substance and final product formulations meet required regulatory specifications throughout the drug development and manufacturing lifecycle.